Statistics for the Plotted Points |
CAFFEINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 89% | 20% | 84% | 24% |
>= Reporting Level | 37 | 103% | 18% | 99% | 12% |
Total | 45 | 100% | 19% | 98% | 13% |
Miscellaneous Statistics for the Samples |
CAFFEINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 45 | 98% | Spiked |
Estimated Values | 9 | 20% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 47 | . | |
False Negatives | 0 | 0% | 0 out of 46 |
Not Spiked | 33 | . | |
False Positives | 0 | 0% | 0 out of 33 |
Statistics for the Plotted Points |
ACETAMINOPHEN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 48 | 110% | 29% | 112% | 26% |
Total | 48 | 110% | 29% | 112% | 26% |
Miscellaneous Statistics for the Samples |
ACETAMINOPHEN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 48 | 98% | Spiked |
Estimated Values | 8 | 16% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 50 | . | |
False Negatives | 1 | 2% | 1 out of 49 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 30 |
Statistics for the Plotted Points |
CODEINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 19 | 85% | 16% | 83% | 18% |
Total | 19 | 85% | 16% | 83% | 18% |
Miscellaneous Statistics for the Samples |
CODEINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 19 | 95% | Spiked |
Estimated Values | 1 | 5% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 20 | . | |
False Negatives | 1 | 5% | 1 out of 20 |
Not Spiked | 60 | . | |
False Positives | 0 | 0% | 0 out of 59 |
Statistics for the Plotted Points |
DEHYDRONIFEDIPINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 21 | 91% | 19% | 94% | 15% |
Total | 21 | 91% | 19% | 94% | 15% |
Miscellaneous Statistics for the Samples |
DEHYDRONIFEDIPINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 21 | 95% | Spiked |
Estimated Values | 6 | 27% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 22 | . | |
False Negatives | 1 | 5% | 1 out of 22 |
Not Spiked | 58 | . | |
False Positives | 0 | 0% | 0 out of 57 |
Statistics for the Plotted Points |
COTININE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 68% | 11% | 72% | 10% |
>= Reporting Level | 34 | 84% | 15% | 82% | 13% |
Total | 40 | 82% | 16% | 79% | 12% |
Miscellaneous Statistics for the Samples |
COTININE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 91% | Spiked |
Estimated Values | 6 | 14% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 44 | . | |
False Negatives | 3 | 7% | 3 out of 44 |
Not Spiked | 36 | . | |
False Positives | 0 | 0% | 0 out of 35 |
Statistics for the Plotted Points |
DILTIAZEM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 9% | . | 9% | 0% |
>= Reporting Level | 39 | 31% | 14% | 32% | 14% |
Total | 40 | 30% | 14% | 32% | 14% |
Miscellaneous Statistics for the Samples |
DILTIAZEM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 95% | Spiked |
Estimated Values | 40 | 95% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 42 | . | |
False Negatives | 2 | 5% | 2 out of 42 |
Not Spiked | 38 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
ALBUTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 84% | 55% | 84% | 57% |
>= Reporting Level | 38 | 62% | 27% | 63% | 26% |
Total | 40 | 63% | 28% | 63% | 26% |
Miscellaneous Statistics for the Samples |
ALBUTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 100% | Spiked |
Estimated Values | 20 | 50% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 0 | 0% | 0 out of 40 |
Not Spiked | 40 | . | |
False Positives | 1 | 3% | 1 out of 39 |
Statistics for the Plotted Points |
SULFAMETHOXAZOLE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 10 | 42% | 35% | 36% | 35% |
>= Reporting Level | 33 | 54% | 38% | 45% | 44% |
Total | 43 | 52% | 37% | 43% | 41% |
Miscellaneous Statistics for the Samples |
SULFAMETHOXAZOLE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 43 | 96% | Spiked |
Estimated Values | 43 | 96% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 45 | . | |
False Negatives | 2 | 4% | 2 out of 45 |
Not Spiked | 35 | . | |
False Positives | 0 | 0% | 0 out of 34 |
Statistics for the Plotted Points |
TRIMETHOPRIM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 92% | 13% | 90% | 11% |
Total | 39 | 92% | 13% | 90% | 11% |
Miscellaneous Statistics for the Samples |
TRIMETHOPRIM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 98% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 1 | 3% | 1 out of 40 |
Not Spiked | 40 | . | |
False Positives | 0 | 0% | 0 out of 39 |
Statistics for the Plotted Points |
WARFARIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 47 | 52% | 21% | 49% | 23% |
Total | 47 | 52% | 21% | 49% | 23% |
Miscellaneous Statistics for the Samples |
WARFARIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 47 | 96% | Spiked |
Estimated Values | 47 | 96% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 50 | . | |
False Negatives | 2 | 4% | 2 out of 49 |
Not Spiked | 30 | . | |
False Positives | 0 | 0% | 0 out of 30 |
Statistics for the Plotted Points |
1,7-DIMETHYLXANTHINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 40 | 110% | 33% | 104% | 28% |
Total | 40 | 110% | 33% | 104% | 28% |
Miscellaneous Statistics for the Samples |
1,7-DIMETHYLXANTHINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 40 | 95% | Spiked |
Estimated Values | 20 | 48% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 43 | . | |
False Negatives | 2 | 5% | 2 out of 42 |
Not Spiked | 37 | . | |
False Positives | 0 | 0% | 0 out of 37 |
Statistics for the Plotted Points |
CARBAMAZEPINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 39 | 92% | 15% | 89% | 15% |
Total | 39 | 92% | 15% | 89% | 15% |
Miscellaneous Statistics for the Samples |
CARBAMAZEPINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 39 | 98% | Spiked |
Estimated Values | 4 | 10% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 40 | . | |
False Negatives | 1 | 3% | 1 out of 40 |
Not Spiked | 40 | . | |
False Positives | 1 | 3% | 1 out of 39 |
Statistics for the Plotted Points |
DIPHENHYDRAMINE-HCL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 37 | 66% | 18% | 62% | 10% |
Total | 37 | 66% | 18% | 62% | 10% |
Miscellaneous Statistics for the Samples |
DIPHENHYDRAMINE-HCL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 37 | 97% | Spiked |
Estimated Values | 17 | 45% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 38 | . | |
False Negatives | 1 | 3% | 1 out of 38 |
Not Spiked | 42 | . | |
False Positives | 0 | 0% | 0 out of 41 |